Horan Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-47,335
Closed -$2.87M 79
2017
Q1
$2.87M Sell
47,335
-1,253
-3% -$76K 0.65% 34
2016
Q4
$2.73M Sell
48,588
-1,066
-2% -$62.4K 0.71% 35
2016
Q3
$2.96M Sell
49,654
-2,129
-4% -$124K 0.78% 34
2016
Q2
$2.85M Buy
51,783
+6,506
+14% +$346K 0.79% 33
2016
Q1
$2.29M Buy
45,277
+11,416
+34% +$559K 0.63% 39
2015
Q4
$1.71M Buy
33,861
+10,228
+43% +$516K 0.47% 40
2015
Q3
$1.11M Buy
+23,633
New +$1.26M 0.33% 42

Other funds holding MRK

Horan Capital Management's MRK Position: Q2 2017 in Review

Horan Capital Management sold out of Merck (MRK) in Q2 2017, closing a stake of 47,335 shares — an estimated $2.87M sold.

Horan Capital Management first reported a position in MRK in Q3 2015 and held it in 7 quarters. The position peaked at $2.96M in Q3 2016. 1,926 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

  • Horan Capital Management reported no remaining Merck position as of Q2 2017 after selling out during the quarter.
  • Horan Capital Management sold 47,335 Merck shares in Q2 2017, an estimated $2.87M.
  • Horan Capital Management first reported a position in Merck in Q3 2015 and held it in 7 quarters.
  • Horan Capital Management's Merck position peaked at $2.96M in Q3 2016.
  • 1,926 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Horan Capital Management's 13F filing for Q2 2017, filed 17 Jul 2017.